Breakthrough Neuromodulation Therapy: Cala Health Today & In the Future

View

For further info on Cala”s efforts check out this article on essential tremors diagnosis guide!

Event Information

Event Topic:
Breakthrough Neuromodulation Therapy: Cala Health Today & In the Future

Event Description:
Cala Health has developed and is commercializing a first-in-class wearable neuromodulation therapy that merges breakthrough neuroscience and technology to deliver personalized care to each patient. Our vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™, is the only non-invasive prescription therapy for essential tremor. At the core of our solution is the ability to signals from the body to adjust our proprietary neuromodulation signals and then continuously monitor the patient to understand their condition. We intend to expand our offering to address a wide array of chronic conditions.

Date/Time:
Date(s) - 03/09/21
8:30 am - 10:30 am

Event Location:
Zoom talk: https://us02web.zoom.us/j/88274227563:

Speaker Information

Event Speaker:
Renee Ryan

Event Speaker Title:
CEO

Event Speaker Company:
Cala Health

Event Speaker Bio:
Breakthrough Neuromodulation Therapy:  Cala Health Today & In the Future
Renee Ryan has 25 years of building category-creating healthcare companies. Prior to joining Cala as CEO in August 2019, she led the health technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies and Goldman Sachs. Renee currently sits on the boards of Cala, Neuropace and RefleXion Medical.

Event Details

Cost:
$0

Add To Calendar

0